25+ year industry executive to oversee Tessa's financial management, investor relations, and business development strategySINGAPORE, April 04, 2022 (Tessa), a clinical-stage cell therapy company developing
Tessa Therapeutics Appoints Wilson W. Cheung as Chief Financial Officer 25+ year industry executive to oversee Tessa’s financial management, investor relations, and business development strategy GlobeNewswire April 04, 2022 SINGAPORE, April 04, 2022 (GLOBE NEWSWIRE) Tessa Therapeutics Ltd. (Tessa), a clinical-stage cell therapy company developing next-generation cancer treatments for hematological malignancies.